{"id":34873,"date":"2020-11-10T15:22:00","date_gmt":"2020-11-10T15:22:00","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=34873"},"modified":"2021-03-18T12:10:20","modified_gmt":"2021-03-18T12:10:20","slug":"reinhard-ortmann","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/","title":{"rendered":"Reinhard Ortmann"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h2>Dr. Reinhard Ortmann<\/h2>\n<h4>Director Companion Diagnostics at QIAGEN<\/h4>\n\t<p>Reinhard Ortmann is Director Oncology &amp; Precision Diagnostics at QIAGEN and focuses on companion diagnostic commercialization. He is responsible for early companion diagnostic and drug launch preparation and alignment with QIAGEN\u2019s pharmaceutical partners. Reinhard worked for many years in pharmaceutical companies, such as Johnson &amp; Johnson and Chiron Biopharmaceutical, and held various sales and marketing positions covering multiple therapeutic areas.<\/p>\nAfter joining the QIAGEN headquarters in Hilden\/D\u00fcsseldorf in 2010, he established a number of collaborations between QIAGEN\u2019s sales, marketing, medical and reimbursement teams with the equivalent teams in pharmaceutical companies.<br>\nReinhard holds a Doctor of Veterinary Medicine degree and is a Graduate Economist.\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1.jpg\" alt=\"Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1\" onerror=\"this.style.display='none'\" sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,<svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/>&#8221; data-srcset=&#8221;https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1-201&#215;300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1-686&#215;1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1-768&#215;1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1-630&#215;940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1-420&#215;627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile_1-315&#215;470.jpg 315w&#8221;>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Commercialization of companion diagnostics\n\t<\/h3>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.qiagen.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.qiagen.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/reinhard-ortmann-dr-med-vet-945830ba\/\" target=\"_blank\" rel=\"noopener noreferrer\">Visit profile<\/a><\/p>\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Dr. Reinhard Ortmann Director Companion Diagnostics at QIAGEN Reinhard Ortmann is Director Oncology &amp; Precision Diagnostics at QIAGEN and focuses on companion diagnostic commercialization. He is responsible for early companion diagnostic and drug launch preparation and alignment with QIAGEN\u2019s pharmaceutical partners. Reinhard worked for many years in pharmaceutical companies, such as Johnson &amp; Johnson and&#8230;<\/p>\n","protected":false},"author":1,"featured_media":34880,"parent":34845,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-34873","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Reinhard Ortmann &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Reinhard Ortmann is Director Oncology &amp; Precision Diagnostics at QIAGEN and focuses on companion diagnostic commercialization.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reinhard Ortmann &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Reinhard Ortmann is Director Oncology &amp; Precision Diagnostics at QIAGEN and focuses on companion diagnostic commercialization.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-18T12:10:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/\",\"name\":\"Reinhard Ortmann &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile.jpg\",\"datePublished\":\"2020-11-10T15:22:00+00:00\",\"dateModified\":\"2021-03-18T12:10:20+00:00\",\"description\":\"Reinhard Ortmann is Director Oncology & Precision Diagnostics at QIAGEN and focuses on companion diagnostic commercialization.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDx\/Biomarkers &#038; Biobanking 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Reinhard Ortmann\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reinhard Ortmann &#8226; BioTech Pharma Summit","description":"Reinhard Ortmann is Director Oncology & Precision Diagnostics at QIAGEN and focuses on companion diagnostic commercialization.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/","og_locale":"en_US","og_type":"article","og_title":"Reinhard Ortmann &#8226; BioTech Pharma Summit","og_description":"Reinhard Ortmann is Director Oncology & Precision Diagnostics at QIAGEN and focuses on companion diagnostic commercialization.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-03-18T12:10:20+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/","name":"Reinhard Ortmann &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile.jpg","datePublished":"2020-11-10T15:22:00+00:00","dateModified":"2021-03-18T12:10:20+00:00","description":"Reinhard Ortmann is Director Oncology & Precision Diagnostics at QIAGEN and focuses on companion diagnostic commercialization.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Reinhard_Ortmann_Qiagen_BioTech_Pharma_Summit_2021_Profile.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/reinhard-ortmann\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"CDx\/Biomarkers &#038; Biobanking 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/"},{"@type":"ListItem","position":3,"name":"Reinhard Ortmann"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=34873"}],"version-history":[{"count":4,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34873\/revisions"}],"predecessor-version":[{"id":36040,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34873\/revisions\/36040"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34845"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/34880"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=34873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}